Thongtang N, Sukmawan R, Llanes EJB, Lee ZV (2022) Dyslipidemia management for primary prevention of cardiovascular events: best in-clinic practices. Prev Med Rep 27:101819

Article  PubMed  PubMed Central  Google Scholar 

Spitz J, Patel J, Agarwala A, Sharma G, Mehta A, Natarajan P, Nasir K, Morris P, Blumenthal RS, Shapiro MD (2025) A critical appraisal of lipid management in the post-statin era: comparison on guidelines, therapeutic targets, and screening in a case-based framework of lipid management. JACC Adv 4:101823

Article  PubMed  PubMed Central  Google Scholar 

Sniderman A, Thanassoulis G, Couture P, Williams K, Alam A, Furberg CD (2012) Is lower and lower better and better? A re-evaluation of the evidence from the cholesterol treatment trialists’ collaboration meta-analysis for low-density lipoprotein lowering. J Clin Lipidol 6:303–309

Article  PubMed  Google Scholar 

Banach M, Penson PE (2020) Statins and LDL-C in secondary prevention-so much progress, so far to go. JAMA Netw Open 3:e2025675

Article  PubMed  Google Scholar 

Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, Chapman MJ, De Backer GG, Delgado V, Ference BA, Graham IM, Halliday A, Landmesser U, Mihaylova B, Pedersen TR, Riccardi G, Richter DJ, Sabatine MS, Taskinen MR, Tokgozoglu L, Wiklund O, ESC Scientific Document Group (2020) 2019 ESC/EAS guidelines for the management of dyslipidaemias lipid modification to reduce cardiovascular risk. Eur Heart J 41(1):111–188

Article  PubMed  Google Scholar 

Zuin M, Rigatelli G, Caldarola P, Colivicchi F, Roncon L, Bilato C (2023) Real-world efficacy of current lipid-lowering strategies in patients with acute coronary syndrome. Time to change the paradigm for treatment. G Ital Cardiol (Rome) 24:30–40

PubMed  Google Scholar 

Mach F, Koskinas KC, van RoetersLennep JE, Tokgözoğlu L, Badimon L, Baigent C, Benn M, Binder CJ, Catapano AL, De Backer GG, Delgado V, Fabin N, Ference BA, Graham IM, Landmesser U, Laufs U, Mihaylova B, Nordestgaard BG, Richter DJ, Sabatine MS, ESC/EAS Scientific Document Group (2025) 2025 focused update of the 2019 ESC/EAS guidelines for the management of dyslipidaemias. Eur Heart J 46(42):4359–4378

Article  PubMed  Google Scholar 

Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, ooney MT, Corrà U, Cosyns B, Deaton C, Graham I, Hall MS, Hobbs FDR, Løchen ML, Löllgen H, Marques-Vidal P, Perk J, Prescott E, Redon J, Richter DJ, Sattar N, Smulders Y, Tiberi M, van Worp HB, van Dis I, Verschuren WMM, Binno S, ESC Scientific Document Group (2016) 2016 European guidelines on cardiovascular disease prevention in clinical practice: the sixth joint task force of the European society of cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of 10 societies and by invited experts)developed with the special contribution of the European association for cardiovascular prevention & rehabilitation (EACPR). Eur Heart J 37:2315–2381

Article  PubMed  PubMed Central  Google Scholar 

SCORE2 working group and ESC cardiovascular risk collaboration (2021) SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe. Eur Heart J 42:2439–2454

Article  Google Scholar 

SCORE2-OP working group and ESC Cardiovascular risk collaboration (2021) SCORE2-OP risk prediction algorithms: estimating incident cardiovascular event risk in older persons in four geographical risk regions. Eur Heart J 42:2455–2467

Article  Google Scholar 

Ray KK, Nicholls SJ, Li N, Louie MJ, Brennan D, Lincoff AM, Nissen SE, CLEAR OUTCOMES Committees and Investigators (2024) Efficacy and safety of bempedoic acid among patients with and without diabetes: prespecified analysis of the CLEAR Outcomes randomised trial. Lancet Diabetes Endocrinol 12:19–28

Article  CAS  PubMed  Google Scholar 

Raal FJ, Rosenson RS, Reeskamp LF, Hovingh GK, Kastelein JJP, Rubba P, Ali S, Banerjee P, Chan KC, Gipe DA, Khilla N, Pordy R, Weinreich DM, Yancopoulos GD, Zhang Y, Gaudet D, ELIPSE HoFH Investigators (2020) Evinacumab for homozygous familial hypercholesterolemia. N Engl J Med 383(8):711–720

Article  CAS  PubMed  Google Scholar 

Duarte Lau F, Giugliano RP (2022) Lipoprotein(a) and its significance in cardiovascular disease: a review. JAMA Cardiol 7:760–769

Article  PubMed  Google Scholar 

Bhatt DL, Steg PG, Miller M, Brinton EA, Jacobson TA, Ketchum SB, Doyle RT Jr, Juliano RA, Jiao L, Granowitz C, Tardif JC, Ballantyne CM, REDUCE-IT Investigators (2019) Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia. N Engl J Med 380:11–22

Article  CAS  PubMed  Google Scholar 

Witztum JL, Gaudet D, Freedman SD, Alexander VJ, Digenio A, Williams KR, Yang Q, Hughes SG, Geary RS, Arca M, Stroes ESG, Bergeron J, Soran H, Civeira F, Hemphill L, Tsimikas S, Blom DJ, O’Dea L, Bruckert E (2019) Volanesorsen and triglyceride levels in familial chylomicronemia syndrome. N Engl J Med 381:531–542

Article  CAS  PubMed  Google Scholar 

Grinspoon SK, Fitch KV, Zanni MV, Fichtenbaum CJ, Umbleja T, Aberg JA, Overton ET, Malvestutto CD, Bloomfield GS, Currier JS, Martinez E, Roa JC, Diggs MR, Fulda ES, Paradis K, Wiviott SD, Foldyna B, Looby SE, Desvigne-Nickens P, Alston-Smith B, Leon-Cruz J, McCallum S, Hoffmann U, Lu MT, Ribaudo HJ, Douglas PS, REPRIEVE Investigators (2023) Pitavastatin to prevent cardiovascular disease in HIV infection. N Engl J Med 389(8):687–699

Article  CAS  PubMed  PubMed Central  Google Scholar 

Newman CB, Preiss D, Tobert JA, Jacobson TA, Page RL 2nd, Goldstein LB, Chin C, Tannock LR, Miller M, Raghuveer G, Duell PB, Brinton EA, Pollak A, Braun LT, Welty FK, American Heart Association Clinical Lipidology, Lipoprotein, Metabolism and Thrombosis Committee, a Joint Committee of the Council on Atherosclerosis, Thrombosis and Vascular Biology and Council on Lifestyle and Cardiometabolic Health; Council on Cardiovascular Disease in the Young; Council on Clinical Cardiology; and Stroke Council (2019) Statin safety and associated adverse events: a scientific statement from the American heart association. Arterioscler Thromb Vasc Biol 39:e38–e81

Article  CAS  PubMed  Google Scholar 

Warden BA, Guyton JR, Kovacs AC, Durham JA, Jones LK, Dixon DL, Jacobson TA, Duell PB (2023) Assessment and management of statin-associated muscle symptoms (SAMS): a clinical perspective from the national lipid association. J Clin Lipidol 17:19–39

Article  PubMed  Google Scholar 

Ray KK, Haq I, Bilitou A, Manu MC, Burden A, Aguiar C, Arca M, Connolly DL, Eriksson M, Ferrières J, Laufs U, Mostaza JM, Nanchen D, Rietzschel E, Strandberg T, Toplak H, Visseren FLJ, Catapano AL, SANTORINI Study Investigators (2023) Treatment gaps in the implementation of LDL cholesterol control among high- and very high-risk patients in Europe between 2020 and 2021: the multinational observational SANTORINI study. Lancet Reg Health Eur 29:100624

Article  PubMed  PubMed Central  Google Scholar 

Gomes DA, Paiva MS, Freitas P, Albuquerque F, Lima MR, Santos RR, Presume J, Trabulo M, Aguiar C, Ferreira J, Ferreira AM, Mendes M (2024) Attainment of LDL-cholesterol goals in patients with previous myocardial infarction: a real-world cross-sectional analysis. Arq Bras Cardiol 121:e20230242

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jianu N, Nițu ET, Merlan C, Nour A, Buda S, Suciu M, Luca SA, Sbârcea L, Andor M, Buda V (2025) A comprehensive review of the latest approaches to managing hypercholesterolemia: a comparative analysis of conventional and novel treatments: part II. Pharmaceuticals (Basel) 18:1150

Article  CAS  PubMed  Google Scholar 

Fathieh S, Tang O, Gray MP, Zanchin C, Vernon ST, Genetzakis E, Tran C, Sullivan DR, Nicholls SJ, Celermajer DS, Psaltis PJ, Grieve SM, Figtree GA (2025) Evaluating the role of lipoprotein(a) in enhancing risk stratification for the presence and extent of subclinical coronary artery disease burden—A BioHEART-CT study. Eur J Prev Cardiol. https://doi.org/10.1093/eurjpc/zwaf323. (Epub ahead of print)

Article  PubMed  Google Scholar 

Manzato M, Wright RS, Jaffe AS, Vasile VC (2024) Lipoprotein(a): underrecognized risk with a promising future. Rev Cardiovasc Med 25:393

Article  PubMed  PubMed Central  Google Scholar 

Razavi AC, Bhatia HS, Blumenthal RS, Shapiro MD, Mehta A (2025) Why, how and in whom should we measure levels of lipoprotein(a): a review of the latest evidence and clinical implications. Diabetes Obes Metab 27:34–46

Article  PubMed  PubMed Central  Google Scholar 

Bilato C, Zuin M, Rigatelli G (2025) Looking for lipoprotein(a) in youngsters: a call to action. J Cardiovasc Med 26:235–239

Article  Google Scholar 

Triant VA, Lyass A, Hurley LB, Borowsky LH, Ehrbar RQ, He W, Cheng D, Lo J, Klein DB, Meigs JB, Grinspoon SK, Plutzky J, Silverberg MJ, LaValley M, Massaro JM, D’Agostino RB Sr (2024) Cardiovascular risk estimation is suboptimal in people with HIV. J Am Heart Assoc 13:e029228

Article  PubMed  PubMed Central  Google Scholar 

Henriquez-Santos G, Kim JE, Kumar SJ, Livinski AA, Vo JB, Zhu F, Joo J, Shearer JJ, Hashemian M, Roger VL (2025) Cardiovascular risk, health metrics, and cancer prediction: a scoping review. JACC CardioOncol 7:593–606

Article  PubMed  PubMed Central  Google Scholar 

Apple SJ, Clark R, Daich J, Gonzalez ML, Ostfeld RJ, Toth PP, Bittner V, Martin SS, Rana JS, Nasir K, Shapiro MD, Virani SS, Slipczuk L (2023) Closing the gaps in care of dyslipidemia: revolutionizing management with digital health and innovative care models. Rev Cardiovasc Med 24:350

Article  PubMed  PubMed Central  Google Scholar 

Rao SV, O’Donoghue ML, Ruel M, Rab T, Tamis-Holland JE, Alexander JH, Baber U, Baker H, Cohen MG, Cruz-Ruiz M, Davis LL, de Lemos JA, DeWald TA, Elgendy IY, Feldman DN, Goyal A, Isiadinso I, Menon V, Morrow DA, Mukherjee D, Platz E, Promes SB, Sandner S, Sandoval Y, Schunder R, Shah B, Stopyra JP, Talbot AW, Taub PR, Williams MS (2025) 2025 ACC/AHA/ACEP/NAEMSP/SCAI guideline for the management of patients with acute coronary syndromes: a report of the American college of cardiology/American heart association joint committee on clinical practice guidelines. Circulation 151:e771–e862